Cara Therapeutics, Inc. CARA
5.32 0.00 0.00%
At close · Apr 15
52-week range unavailable
- YTD
- -71.02%
- 1 year
- -79.19%
- Open
- 4.80
- Prev close
- 5.32
- Mkt cap
- 25.09M
- Vol
- 236.84K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.28
- High
- 5.52
- Forward P/E
- -0.59
- Beta
- 0.68
- Short ratio
- 2.20
- Inst. own
- 28.16%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.29152
- 200-d avg
- 0.46241
- 1y target
- 1.01
MAX chart
Chart tools
Chart is warming up
The all-time price history for CARA has not been loaded yet. Try again in a moment.
Altman Z-Score
-9.74 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -6.5×
P/S 0.0×
P/B 5653×
P/FCF -5039×
EV/EBITDA 1246186×
EV/Sales 0.0×
FCF Yield -0.0%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -87.0%
ROIC -126.5%
ROA -56.8%
Revenue -100.0%
Operating Income 54.2%
EPS (diluted) -110.3%
Free Cash Flow 62.1%
Current Ratio 2.9×
Quick Ratio 2.9×
Debt / Equity 0.0×
Net Debt / EBITDA -216×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31